Vestre Viken HF

Research site

Norway Sogneprest Munthe-Kaas Vei 100, 1346 Gjettum, Norway

5 trials recruiting
Chronic kidney disease · Sepsis · Ischaemic stroke
Adult patients

About Specializations

Vestre Viken HF in Gjettum, Norway specialises in clinical trials of conditions such as Chronic kidney disease, Sepsis, Ischaemic stroke, Crohn's disease, and other specialisations. This site conducts important research.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location

Sogneprest Munthe-Kaas Vei 1001346 GjettumNorway

Open in maps ↗

Recruiting now: 5 trials
Conditions studied: 5

More sites in Gjettum Norway

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Quick filters

5 clinical trials

Chronic kidney disease

Recruiting

Randomized Phase III trial of elecoglipron plus dapagliflozin on kidney outcomes and mortality in adults with chronic kidney disease

Registered drug

Randomized Phase III trial of elecoglipron plus dapagliflozin on kidney outcomes and mortality in adults with chronic kidney disease

Registered drug

Norway

Participants:18–64 years · 65+ years
Substances:AZD5004
Sponsor:AstraZeneca AB

Contact Research Centre

Sepsis

Recruiting

Comparison of Gentamicin with Narrow-Spectrum Antibiotics versus Broad-Spectrum Antibiotics in Adult Patients with Early Sepsis

Registered drugNo placebo

Comparison of Gentamicin with Narrow-Spectrum Antibiotics versus Broad-Spectrum Antibiotics in Adult Patients with Early Sepsis

Registered drugNo placebo

Norway

Participants:18–64 years · 65+ years
Substances:Ampicillin Sodium
Sponsor:Akershus University Hospital

Contact Research Centre

Ischaemic stroke

Recruiting

Study on the Effectiveness of Tenecteplase in Patients with Acute Ischemic Stroke Taking Rivaroxaban, Apixaban, or Edoxaban

Registered drugNo placebo

Study on the Effectiveness of Tenecteplase in Patients with Acute Ischemic Stroke Taking Rivaroxaban, Apixaban, or Edoxaban

Registered drugNo placebo

Norway

Participants:18–64 years · 65+ years
Substances:Alteplase
Sponsor:Oslo University Hospital Hf

Contact Research Centre

Crohn's disease

Recruiting

Study on the Effectiveness and Safety of Vedolizumab and Upadacitinib in Adults with Moderate to Severe Crohn's Disease

Registered drug

Study on the Effectiveness and Safety of Vedolizumab and Upadacitinib in Adults with Moderate to Severe Crohn's Disease

Registered drug

Norway

Participants:18–64 years · 65+ years
Substances:Upadacitinib
Sponsor:Takeda Development Center Americas Inc.

Contact Research Centre

Respiratory tract infection viral

Recruiting

Study on Stopping Antibiotics in Adults with Viral Respiratory Infections Using Tetracyclines and Other Antibiotics

Registered drugNo placebo

Study on Stopping Antibiotics in Adults with Viral Respiratory Infections Using Tetracyclines and Other Antibiotics

Registered drugNo placebo

Norway

Participants:18–64 years · 65+ years
Sponsor:Akershus University Hospital

Contact Research Centre

Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites